Aim: To clarify the cause of poor oral absorption of ginsenoside Rg 1 (Rg 1 ), the active ingredient in Panax notoginseng saponins (PNS) used for treating hemorrhage. Methods: Caco-2 cell monolayers were used as an in vitro model to study the transport mechanism of Rg 1 across the intestinal mucosa. Moreover, the serum concentration-time profiles after peroral (po), intraduodenal (id), portal venous (pv) and tail venous (iv) administration of Rg 1 in rats were compared to evaluate the first-pass effects in the stomach, intestine, and liver. Results: Uptake of Rg 1 by Caco-2 cell monolayers was temperature-dependent, but was not influenced by cyclosporin A. The change in the apical pH produced no obvious effect on the uptake of Rg 1 . The uptake and transport of Rg 1 was non-saturable; whereas the flux from the apical compartment to the basolateral compartment (A− B) increased in a linear manner with the increase in concentration, indicating passive transport. An apparent permeability coefficient of (2.59±0.17)×10
Introduction
Ginsenoside Rg 1 (Rg 1 ), the main ingredient of Panax notoginseng saponins (PNS; an important traditional Chinese medicine), has been proven in recent years to possess a number of pharmacological effects, including partial protection against the excitotoxic effect of glutamate in primary hippocampal cultures [1] , a partial neurotrophic and neuroprotective role in dopaminergic cell culture [2] , an ameliorating effect on performance impairment induced by scopolamine [3] , and a protective effect on experimental myocardial injury induced by ischemia and reperfusion in rats [4] . Rg 1 is poorly absorbed when administered orally, but in addition to factors such as solubility and dissolution related to its high aqueous solubility, it is possible that other factors contribute to its poor absorption. It has been reported in recent years that Rg 1 is decomposed in gastric juice [5] and transformed into 20(S)-protopanaxatriol (20S-Ppt) via ginsenoside Rh 1 by enteric bacteria in rats and humans [5] [6] [7] [8] [9] . This suggests the instability of Rg 1 in the stomach and large intestine. The pharmacokinetics of Rg 1 in rats have been studied through TLC and the results show that little Rg 1 is absorbed from the digestive tract [5, 10] . Rg 1 has been reported to be efficiently taken up by the rat liver and secreted into bile, and 57.2%±1.7% of the dose was found to be excreted into bile within 4 h after iv administration at a dose of 5 mg/kg [10] . However, what remains unknown is the transport mechanism across the intestinal mucosa and the firstpass effects of the stomach, intestine and liver which are involved in the absorption process. In order to improve the oral absorption of Rg 1 , it is necessary to clarify the absorption mechanism systematically.
The first-pass effects of the stomach, intestine and liver can be evaluated by comparing the absolute bioavailability (F po , F id and F pv respectively), which are calculated by dividing the area under the serum concentration versus time curve (AUC) after po, id, and pv administration by the AUC after iv administration [12, 13] . Because PNS is used more widely in practice than Rg 1 alone, both Rg 1 and PNS (Rg 1 content of 27.36%) are investigated in the present study.
Materials and methods
Materials PNS was purchased from Kunming Pharmaceutical Co (Kunming, China). Standard ginsenoside Rg 1 was purchased from the National Institute for the Control of Pharmaceutical and Biological Products, China. Cyclosporin A (CsA) was obtained from the Guangdong Medicine Group Co, Ltd (Guangzhou, China). The Caco-2 cell line was obtained from the American Type Culture Collection (Rockville, MD, USA) at passage 35. Cell culture media and reagents including fetal bovine serum were purchased from Gibco (Grand Island, NY, USA). Permeable polycarbonate inserts and Millicell-ERS (electrical resistance system) were purchased from Millipore (Bedford, MA, USA). All other chemicals and reagents were of analytical or high performance liquid chromatography (HPLC) grade as appropriate.
Caco-2 cell culture Caco-2 cells at passages 35-42 were used in the experiments and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 1% L-glutamate, 1% nonessential amino acids and 1% penicillin streptomycin solution at 37 o C in 75-cm 2 flasks (Costar) in a humidified air-5% CO 2 atmosphere. After being harvested with trypsin-ethylenediamine tetraacetic acid (EDTA), cells in suspension (2.5×10 5 cells/mL) were seeded onto 6-well plates for Rg 1 uptake studies (2 mL/well) and on permeable polycarbonate inserts (4.2 cm 2 , 0.40 µm pore size) in 6-well plates (Nunc, Roskilde, Denmark) for transepithelial transport studies (1 mL cell suspension in the apical compartment and 2 mL culture medium in the basolateral compartment). Cells were cultured for 14 d for uptake studies and 20-22 d for transepithelial transport studies after seeding. The transepithelial electrical resistance (TEER) of the Caco-2 cell monolayers was examined routinely before and after the experiment using the Millicell-ERS system to assess the integrity of monolayers grown on the permeable membrane in the transepithelial transport studies. The monolayers were used when TEER exceeded 500 Ω·cm
.
Uptake studies Rg 1 uptake was measured using monolayers grown in 6-well plates. The uptake medium consisted of Hanks' balanced salt solution (HBSS) with calcium and magnesium, 25 mmol/L D-glucose, 20 mmol/L N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; adjusted to pH 7.0 or 7.4 with 1 mol/L HCl) or 2-N-morpholineethanesulfonic acid (MES; adjusted to pH 5.5, 6.0 or 6.5 with 1 mol/L NaOH). The medium pH was measured and adjusted after addition of all compounds tested in uptake studies. For Rg 1 uptake measurements, cells were washed with HBSS (3×2 mL) at the appropriate pH and preincubated for 15 min in 2 mL HBSS at controlled temperatures (4 or 37 o C). The medium was discarded, and Rg 1 uptake was studied after various incubation times at different final concentrations. Cyclosporin A was added to the incubation medium on the cell monolayers to investigate its effect on Rg 1 uptake. At the end of the incubation period, the incubation solution was aspirated and the monolayers were carefully rinsed with ice-cold HBSS. Each Caco-2 cell monolayer was collected with 1 mL HBSS and frozen (at -80 o C) then thawed (at room temperature) 3 times, and then the cells were lysed ultrasonically. After the solubilized monolayers were centrifuged at 9000×g for 10 min, the supernatants were collected and 10 µL was used to determine the Rg 1 concentration using HPLC. Results were expressed as µg of Rg 1 per mg of protein. The protein contents of the cell monolayers were determined by using Coomassie staining.
Transepithelial transport study For Rg 1 transepithelial flux measurement, Caco-2 cell monolayers were washed 3 times with prewarmed (37 o C) HBSS prior to the experiments. Then the monolayers were preincubated at 37 o C for 15 min in a CO 2 incubator with warm (37 o C) HBSS (pH 6.5 and 7.4 for the apical and basolateral compartments, respectively). The TEER was measured to ensure that the epithelium was tight, and the HBSS solution on both sides of the cell monolayers was then removed by aspiration. Rg 1 or PNS was added to either the apical (1.5 mL; pH 6.5) or basolateral (2 mL; pH 7.4) compartments. At various times, samples (200 µL) were taken from the opposite compartment followed by immediate replacement with fresh HBSS of the same volume (200 µL). Ten microliters was used to determine the Rg 1 concentration using HPLC. All experiments were conducted in triplicate. Results were expressed as µg of Rg 1 transported per cm 2 of epithelium.
The drug transport capacity of the epithelium was quantified by calculating the apparent permeability coefficient (P app ) that reflects the passage velocity of the drug through the epithelium. P app was calculated as follows:
where dQ/dt is the drug permeation rate (µg/s), A is the sur-face area of epithelium (cm 2 ), and C 0 is the initial concentration in the donor compartment (µg/cm 3 ). First-pass effects of Rg 1 The first-pass effects of Rg 1 were evaluated after po, id, pv and iv administration of PNS to rats. Male Sprague-Dawley rats weighing 250-300 g were used. They were fasted with free access to water for 20 h prior to po and id administration. For iv administration, PNS dissolved in 0.9% NaCl solution (50 mg/mL) was given via the tail vein at a dose of 50 mg/kg. For pv administration, the rats were anesthetized lightly with diethyl ether, the portal vein was surgically exposed, and PNS dissolved in 0.9% NaCl solution (50 mg/mL) was delivered into the portal vein through the mesenteric vein over 15 s at a dose of 50 mg/kg. For po and id administration, PNS dissolved in water was administered perorally at doses of 600 mg/kg or 1500 mg/kg (dose volume 6 mL/kg), and intraduodenally at doses of 600, 900 or 1200 mg/kg (dose volume 4 mL/kg). Blood samples were collected from the eye socket at 0.08, 0.25, 0. Model-independent methods based on the theory of statistical moments were used to characterize the pharmacokinetics of Rg 1 after iv, id, pv and po administration of Rg 1 . AUC and mean residence time (MRT) were calculated by numerical integration under the trapezoidal rule as described by Yamaoka et al [14] . Because this was observed over a limited period of time (72 h), extrapolation to time=infinity was carried out using a monoexponential equation. The absolute bioavailability (F) of Rg 1 was calculated by dividing AUC after po, id, and pv administration by the AUC after iv administration.
Determination of Rg 1 by HPLC Solid phase extraction (SPE) cartridges (Oasis, Waters, USA) were conditioned under vacuum with 1 mL of methanol and 1 mL of water. Then, 200 µL of serum samples were mixed with 4 µL of 85% (v/v) phosphoric acid, and centrifuged at 9000×g for 10 min. A volume of 100 µL of supernatant was applied to the SPE cartridges and drawn through under low vacuum (10-15 in Hg). Cartridges were washed with 1 mL of 5% (v/v) methanol aqueous solution, eluted with 1 mL of methanol and evaporated to dryness under a nitrogen stream at 40 o C. Finally, the residues were reconstituted in 100 µL of the mobile phase and 10 µL was used for HPLC.
HPLC was carried out using a YMC ODS C 18 column (5 µm, 4.2 ID×150 mm, Japan) with a liquid chromatograph (LC-10AT; Shimadzu, Japan) and a UV-VIS Detector (SPD-101; Shimadzu) at 203 nm, and a data workstation system (HS2000; Hangzhou Empire, Hangzhou, China). A mobile phase at a speed of 1 mL/min consisting of acetonitrile with 20 mmol/L NaH 2 PO 4 (32:68, v/v) was used for chromatographic resolution. The peak area was linearly related to the amount of Rg 1 over the range of 10.8-432 ng. The within-day precision of determination of Rg 1 in rat serum by using HPLC was 3.45%, 6.36%, and 4.66% for 21.6, 108, and 432 ng Rg 1 , respectively. The between-day precision of determination of Rg 1 in rat serum by HPLC was 5.40%, 9.18%, and 7.32% for 21.6, 108, and 432 ng Rg 1 respectively. The recovery of Rg 1 in rat serum were 85.24%±2.96%, 86.11%±5.48%, and 81.61%±3.80% for 21.6, 108, and 432 ng Rg 1 , respectively.
Statistical analysis Values are expressed as mean±SD. The difference among mean values was analyzed by using the two-tailed Student's t-test and comparisons among more than 3 groups were performed by using one-way ANOVA. P<0.05 was considered to be significant.
Results
Uptake of Rg 1 by Caco-2 cell monolayers Rg 1 (1 mg/mL) and PNS (4 mg/mL) uptake by Caco-2 cell monolayers was studied at 37 o C and 4 o C. The intracellular amounts sharply increased during the first 30 min and reached almost a steady state afterwards (Figure 1 ). For both Rg 1 alone and Rg 1 in PNS, uptake was temperature-dependent, and intracellular Rg 1 amounts measured at 37 o C were approximately 1.5-fold higher than those at 4 o C. In addition, the pH-dependence of Rg 1 (or PNS) uptake was examined. No significant difference was observed when Caco-2 cell monolayers were incubated with Rg 1 (or PNS) solution at different pH levels (pH 5.5, 6.0, 6.5, 7.0, 7.4; Table  1 ). Given the weak acid microclimate that exists above the epithelial cell layer in the upper part of the small intestine [15] , the following studies were performed at pH 6.5 on the apical side of the monolayer.
The concentration-dependence of uptake of Rg 1 by Caco-2 cell monolayers was examined. The intracellular amounts of Rg 1 at 37 o C and 4 o C increased linearly with the increase in concentration over the range of 0.25 mg/mL to 5 mg/mL for Rg 1 , and 1 mg/mL to 40 mg/mL for PNS (Figure 2 ), which indicates passive membrane diffusion.
CsA was used as a P-gp and MRP inhibitor to investigate the role of efflux transporters in Rg 1 uptake. In the absence and presence of CsA (50 µmol/L), Rg 1 uptake was 1.027±0.056 and 0.986±0.093 µg/mg protein, respectively, for 1 mg/mL Rg 1 solution (n=3), and 0.826±0.055 and 0.840± 0.054 µg/mg protein, respectively, for 4 mg/mL PNS solution (n=3). No effect was observed when CsA was present. The results further confirmed that Rg 1 uptake was not mediated by the efflux transporters in Caco-2 cell monolayers.
Transepithelial transport studies Rg 1 transepithelial transport across Caco-2 cell monolayers was measured to evaluate intestinal permeability. Transport velocity from the apical to the basolateral (A-B) compartment was approximately constant during the whole kinetic study at 37 o C (Figure 3) . The amount of Rg 1 cumulative transepithelial flux through Caco-2 cell monolayers over 180 min increased linearly with increasing concentration in the apical compartment. P app was (2.66±0.41)×10 -7 , (2.44±0.09)×10 -7 , (2.59±0.17)×10 -7 and (2.19±017)×10 -7 cm/s when the initial Rg 1 concentration in apical compartment was 0.2, 0.5, 1.0, and 3.0 mg/mL, respectively (n=3). In the presence of CsA (50 µmol/L), P app (A-B) was (2.45±0.20)×10 -7 cm/s when Rg 1 was 1 mg/mL (n=3). Thus, the P app (A-B) of Rg 1 was not significantly different at any concentration tested or in the presence of CsA. However, the P app (B-A) was (1.13±0.11)×10 -7 cm/s when Rg 1 was 1 mg/mL in the basolateral compartment (n=3), which is significantly lower than that of A-B transport (P<0.05).
Gastric, intestinal and hepatic first-pass effects of Rg 1 The gastric, intestinal and hepatic first-pass effects were evaluated after po, id, pv and iv administration. Figure 4 shows the serum concentration-time profiles of Rg 1 after iv and pv administration of PNS. For each route of administration, 2 phases of decline were observed: a rapid decline followed by a slow decline, which could be described by a 2-compartment model. The pharmacokinetic parameters are listed in Table 2 . AUC 0-8 of Rg 1 after pv administration of PNS (50 mg/kg) in rats was lower (approximately 49.44%) than that after iv administration of PNS (50 mg/kg). This indicates that part of the dose disappeared (may be due to biliary excretion) following the first pass through the liver after pv administration. After pv administration, the MRT 0−8 value decreased by approximately 50% compared with iv administration, which could be due to the hepatic first-pass effect after pv administration.
After po administration of PNS at a dose of 600 mg/kg, no Rg 1 could be detected in serum samples. However, after po administration of 1500 mg/kg PNS in rats, the serum concentration of Rg 1 was low, could be detected 2 h after administration, and reached a peak (5.38 µg/mL) 6 h after administration ( Figure 5 ). Absolute bioavailability (F po ) was estimated to be 3.29%. After id administration of PNS at Table 2 . Pharmacokinetic parameters of Rg 1 after iv (50 mg/kg), pv (50 mg/kg), and po (A: 600 mg/kg; B: 1500 mg/kg), id (A: 600 mg/kg; B: 900 mg/kg; C: 1200 mg/kg) administration of PNS solution in rats. Data doses of 600 mg/kg, 900 mg/kg and 1200 mg/kg in rats, absolute bioavailability (F id ) was, respectively, 1.52%, 3.41%, and 6.60% ( Figure 5 ). For a dose of 600 mg/kg PNS administered via the iv route, the serum concentration was below quantification limits more than 8 h after id administration. Thus, a comparison of F po with F id , and F id with F pv shows that the gastric and intestinal first-pass effects are both significant.
Discussion
Modulation of Rg 1 uptake by a P-glycoprotein (P-gp; or MRP)-related efflux mechanism or enzymatic degradation in Caco-2 monolayers as possible explanations for the low Rg 1 uptake were excluded in the present study because we observed neither concentration-dependence for Rg 1 uptake nor any effect of co-administration of CsA on the Rg 1 uptake.
The Rg 1 uptake by Caco-2 cell monolayers was pHindependent, and greater uptake occurred at 37 o C compared with that at 4 o C. This temperature-dependence of uptake might be attributed to the cell membranes being more rigid at low temperatures, leading to a lower level of diffusion through the membrane [16] . In the transepithelial transport study, the flux of Rg 1 in the A-B direction increased in a linear fashion with increasing concentration in the apical compartment, and no significant difference was observed after the addition of CsA. These results confirm that Rg 1 is passively transported across Caco-2 cell monolayers. P app (A-B) was approximately 2-fold greater than P app (B-A). This polarized transport occurring in Caco-2 cell monolayers may result from the differences in physiological structure between the apical (A) and basolateral (B) membranes. P app (A-B) was estimated to be (2.59±0.17)×10 -7 cm/s (C 0 =1 mg/mL), which is below the suggested threshold value (1×10 -5 cm/s) for poorly absorbed drugs [17] . The relatively large molecular weight (M r =801) and low lipophilia value (we found that log P, the log value of the coefficient between water and octanol, was 0.64) of Rg 1 may be partly responsible for its low permeability.
After pv administration of PNS in rats, serum concentration-time profiles of Rg 1 were found to be similar to those observed with iv administration, but the AUC value decreased, which may have been caused by bile excretion following the first pass through the liver. For po administration of PNS at a dose of 1500 mg/kg, a delayed peak in serum concentration of Rg 1 can be attributed to the low rate of absorption or the potential specific absorptive sites in the lower part of the intestine instead of biliary excretion, because the amount of biliary excretion is small compared with the po dose given in this instance. In contrast, few serum samples could be quantified after po administration of PNS at a dose of 600 mg/kg. With id administration, rapid absorption and a short time to peak serum concentration was observed, which was caused by the high concentration in the local area when PNS was directly delivered to the duodenum. Owing to the saturation of the enzymes in the intestinal tract when a higher dose was administered, absorption of Rg 1 after id administration is dose-dependent, and the absolute bioavailability values were 1.52%, 3.41% and 6.60% for dosages of 600 mg/kg, 900 mg/kg and 1200 mg/kg, respectively.
As a result, the gastric first-pass effect is significant when F po (3.29% at a dose of 1500 mg/kg PNS) is compared with F id (6.60% at a dose of 1200 mg/kg PNS), probably relating to the decomposition of Rg 1 in the acid pH of the stomach [5] . However, although the gastric first-pass effect is significant, a large amount of Rg 1 remains intact after po administration and moves into the intestinal tract, which may also induce saturation of enzymes in the intestinal tract and produce a similar F value to id administration at a relative low dose. Consequently, the primary reason for poor absorption of Rg 1 can be attributed to the intestinal first-pass effect, because F id is still extremely low (6.60% at a dose of 1200 mg/kg PNS), and approximately 7-8 times lower than F pv (50.56%). There are two factors that account for the intestinal firstpass effect. One is metabolism by bacterial β-glucuronidase in the large intestine, but this is not a key factor, because the enzymatic reaction with microflora takes place mainly in the large intestine, but the small intestine is known to be a more important location in the absorption process. Furthermore, it is the low permeability across the intestinal mucosa of Rg 1 that mainly accounts for its poor absorption before reaching the portal vein. This is consistent with the results of our Caco-2 cell studies, in which an extremely low P app indicated a poor membrane permeability for Rg 1 .
Therefore, the low bioavailability of Rg 1 is caused by its decomposition in the stomach, metabolism in the large intestine, low membrane permeability across the intestinal mucosa and elimination in the liver. Of these factors, low membrane permeability is the dominant factor explaining the poor absorption of Rg 1 .
